Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · January 21, 2022

Obesity Modifies the Performance of Fibrosis Biomarkers in NAFLD

The Journal of Clinical Endocrinology and Metabolism

 

Additional Info

The Journal of Clinical Endocrinology and Metabolism
Obesity Modifies the Performance of Fibrosis Biomarkers in Nonalcoholic Fatty Liver Disease
J. Clin. Endocrinol. Metab. 2021 Dec 31;[EPub Ahead of Print], S Qadri, N Ahlholm, I Lønsmann, P Pellegrini, A Poikola, PK Luukkonen, K Porthan, A Juuti, H Sammalkorpi, AK Penttilä, R D'Ambrosio, G Soardo, DJ Leeming, M Karsdal, J Arola, S Kechagias, S Pelusi, M Ekstedt, L Valenti, H Hagström, H Yki-Järvinen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading